Canada’s upstream oil and gas sector is in intensive care
The economic damage to the energy industry is due largely to government regulatory and tax policies
Read MoreThe economic damage to the energy industry is due largely to government regulatory and tax policies
Read MoreThere’s no escaping the fact that discovering, developing and testing new drugs costs a lot of money
Read MoreBurdensome regulation, limited competition and unfavourable taxes hold Canadian companies back
Read MoreA shift in U.S. drug pricing could cut pharmaceutical profits, meaning less money for research and development
Read MoreThere’s been no growth in years in the corporate assets that help make companies more efficient and profitable
Read More